Benitec Biopharma (BNTC) Short-term Investments (2021 - 2025)
Benitec Biopharma (BNTC) reported Short-term Investments of $100000.0 for Q4 2025, up 61.29% on a YoY basis from $62000.0 in Q4 2024, and down 11.5% sequentially from $113000.0 in Q3 2025.
Benitec Biopharma (BNTC) Short-term Investments (2021 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 5 years of Short-term Investments data on file, last reported at $100000.0 in Q4 2025.
- For the quarter ending Q4 2025, Short-term Investments rose 61.29% year-over-year to $100000.0; the trailing twelve-month figure through Dec 2025 stood at $100000.0 (up 61.29% YoY), and the FY2025 full-year result was $113000.0, up 79.37% from the prior year.
- Short-term Investments slipped to $100000.0 in Q4 2025, from $113000.0 in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $113000.0 in Q2 2025 to a low of $13000.0 in Q3 2022.
- A 5-year average of $42533.3 and a median of $14000.0 in 2022 frame the typical range for Short-term Investments.
- Across the five-year window, Short-term Investments dropped 7.14% in 2023 and soared 392.31% in 2024, its largest moves.
- Tracing BNTC's Short-term Investments over 5 years: stood at $15000.0 in 2021, then fell by 6.67% to $14000.0 in 2022, then changed by 0.0% to $14000.0 in 2023, then soared by 342.86% to $62000.0 in 2024, then soared by 61.29% to $100000.0 in 2025.
- Business Quant data shows BNTC's Short-term Investments at $100000.0 in Q4 2025, $113000.0 in Q3 2025, and $113000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 113,000.00 |
| Jun 30, 2025 | 113,000.00 |
| Dec 31, 2024 | 62,000.00 |
| Sep 30, 2024 | 64,000.00 |
| Jun 30, 2024 | 63,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Jun 30, 2023 | 13,000.00 |
| Mar 31, 2023 | 14,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Sep 30, 2022 | 13,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Jun 30, 2021 | 15,000.00 |